rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Henry Schein, Inc.

HSIC · Nasdaq

Health CareHealth Care DistributionLeading

HSIC stood above a rising 150-day average in 42 of the last 52 weekly readings, including each of the last 21 weeks. It is 5.9% above that average now. Health Care Distribution: 20% of its 10 stocks in an uptrend (−10 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
21 in a row
Industry in uptrend
20% -10 in 4 wk
Insider buys, 12 months
$1.4M
Insider sales, 12 months
$17.2M
Officials’ trades on record
30

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 42 of 52 weeks.

17 Apr – 16 Oct
1%20%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Health Care Distribution: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$8.8M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

30 disclosed lines: House 24, Senate 4, executive 2; 14 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k11 May 2026filed 1 Jul 2026
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08bought$1k–$15k8 Apr 2025filed 8 May 2025
Julie Johnson House: U.S. House ClerkTX32soldjoint$1k–$15k1 Apr 2025filed 14 May 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k31 Mar 2025filed 7 Apr 2025
Susan M. Collins Senate: U.S. Senate eFDSenatorsoldspouse$15k–$50k6 Jan 2022filed 17 Feb 2022
Eric S. Lander Executive branch: Office of Government EthicsOffice of Science and Technology Policysold$15k–$50k10 Jun 2021filed 8 Sep 2021
Peter Meijer House: U.S. House ClerkMI03sold$15k–$50k16 Feb 2021filed 16 Mar 2021
Lois Frankel House: U.S. House ClerkFL21sold$1k–$15k7 Aug 2020filed 24 Aug 2020
Greg Gianforte House: U.S. House ClerkMT00sold$50k–$100k12 Sep 2019filed 20 Oct 2019
Lois Frankel House: U.S. House ClerkFL21bought$1k–$15k9 May 2019filed 21 May 2019
David B. McKinley House: U.S. House ClerkWV01sold$1k–$15k20 Dec 2018filed 9 Jan 2019
David B. McKinley House: U.S. House ClerkWV01sold$15k–$50k17 Dec 2018filed 9 Jan 2019

Insiders

Buy orders, 12 months1
Sale orders, 12 months7
Buyers · sellers1 · 5
WhoDidSharesTraded
William K. DanielDirectorbought10,000at $69.1911 May 2026filed 12 May 2026
Thomas C. PopeckCEO, Henry Schein Productssold1,355at $72.7919 Mar 2026filed 20 Mar 2026
Kurt P. KuehnDirectorsold2,844at $78.9610 Mar 2026filed 11 Mar 2026
Philip A. LaskawyDirectorsold2,844at $80.365 Mar 2026filed 6 Mar 2026
Mark E. MlotekEVP, Chief Strategic Officersold4,100at $80.804 Mar 2026filed 6 Mar 2026
Mark E. MlotekEVP, Chief Strategic Officersold1,825at $80.814 Mar 2026filed 6 Mar 2026
Stanley M. BergmanChairman, CEOsold23,858at $81.312 Mar 2026filed 3 Mar 2026
Stanley M. BergmanChairman, CEOsold19,954at $81.312 Mar 2026filed 3 Mar 2026
Stanley M. BergmanChairman, CEOsold10,785at $81.2027 Feb 2026filed 27 Feb 2026
Stanley M. BergmanChairman, CEOsold31,134at $80.9026 Feb 2026filed 27 Feb 2026
Stanley M. BergmanChairman, CEOsold7,212at $81.5126 Feb 2026filed 27 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Andrea Albertini Company insiderCEO, Global Dist. & Tech. · last 8 Sep 20260 · 0
William K. Daniel Company insiderDirector · last 12 Jun 20262 · 0
Stanley M. Bergman Company insiderOther · last 26 May 20260 · 36
Donald J. Trump Executive branchWhite House Office · last 11 May 20260 · 1
Thomas C. Popeck Company insiderCEO, Henry Schein Products · last 19 Mar 20260 · 1
Michael S. Ettinger Company insiderEVP & Chief Operating Officer · last 17 Mar 20260 · 13
Christine Zayac Sheehy Company insiderSVP, Chief Human Res. Officer · last 16 Mar 20260 · 0
Mark E. Mlotek Company insiderEVP, Chief Strategic Officer · last 16 Mar 20260 · 29
Ronald N. South Company insiderSVP & Chief Financial Officer · last 16 Mar 20260 · 0
Kurt P. Kuehn Company insiderDirector · last 10 Mar 20261 · 6
Anne H. Margulies Company insiderDirector · last 6 Mar 20261 · 0
Bradley T. Sheares Company insiderDirector · last 6 Mar 20261 · 2

Same industry

MCK McKessonAbove a falling average+19%
COSM Cosmos HealthAbove a falling average+17%
COR CencoraAbove a falling average+12%
HLF HerbalifeAbove a falling average+11%
NUS Nu Skin EnterprisesNot moving yet-10%
ZSTK ZeroStackNot moving yet-11%
MEDS DataMeds AINot moving yet-31%

Distance from each stock’s own 150-day average.

Government contracts

Awards236
Total$758K
Latest1 Oct 2026
2022$14K
2023$12K
2024$2,651
2025$52K
2026$677K

From its SEC filings

Profit per saleFY 2025 · to 27 Dec 202531.1%
Operating profit marginFY 2025 · to 27 Dec 20255.0%
Free cash flow marginFY 2025 · to 27 Dec 20254.3%
Return on capital employedFY 2025 · to 27 Dec 20258.2%
Cash conversionFY 2025 · to 27 Dec 2025179%
Debt to equityFY 2025 · to 27 Dec 20250.24×
Interest coverFY 2025 · to 27 Dec 20254.35×
Share count trendFY 2025 · to 17 Feb 2026-0.9%
Cash and equivalentsFY 2025 · to 27 Dec 2025$156.0M
Free cash flowFY 2025 · to 27 Dec 2025$573.0M

Analyst forecasts

No analyst forecasts yet.